Related Experiment Videos
Improving Catalytic Efficiency and Changing Substrate Spectrum for Asymmetric Biocatalytic Reductive Amination
1Department of Bioengineering and Biotechnology, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian, 361021, P.R. China.
Engineered phenylalanine dehydrogenase (PheDH) enzymes offer a greener route for synthesizing chiral amino acids from ketones. Mutants show enhanced efficiency and broad substrate acceptance for pharmaceutical applications.
Area of Science:
- Biocatalysis and Enzyme Engineering
- Organic Synthesis
- Pharmaceutical Chemistry
Background:
- Enzymes are valuable biocatalysts for synthesizing chiral amino acids, crucial pharmaceutical intermediates.
- Reductive amination of ketones using enzymes provides a sustainable synthetic approach.
- Phenylalanine dehydrogenase (PheDH) is a key enzyme in amino acid metabolism.
Purpose of the Study:
- To engineer a robust phenylalanine dehydrogenase (PheDH) with an expanded substrate spectrum and improved catalytic efficiency.
- To identify key amino acid residues in the active site of PheDH that influence substrate binding and catalysis.
- To develop novel biocatalysts for the efficient production of chiral amino acids.
Main Methods:
- Rational enzyme design and site-specific mutagenesis were employed to modify the parent PheDH from *Bacillus halodurans*.
- Active site residues involved in substrate binding were identified through structural analysis.
- Enzyme activity was assessed for both oxidative deamination and reductive amination reactions.
Main Results:
- A mutant PheDH (E113D-N276L) exhibited a 6.06-fold increase in catalytic rate for oxidative deamination and a 1.58-fold increase for reductive amination.
- The engineered PheDH demonstrated broad substrate specificity, accepting both benzylic and aliphatic ketones.
- The enzyme displayed high catalytic efficiency, selectivity, and enhanced thermal stability.
Conclusions:
- Engineered PheDH enzymes represent a significant advancement in biocatalytic synthesis of chiral amino acids.
- The developed broad-spectrum enzymes hold potential for applications as diagnostic reagents and in pharmaceutical compound development.
- Rational design and mutagenesis are effective strategies for enhancing enzyme performance and expanding their utility.
Related Concept Videos
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
Preparation of Amines: Reductive Amination of Aldehydes and Ketones
Reduction of Alkynes to cis-Alkenes: Catalytic Hydrogenation
Like alkenes, alkynes can be reduced to alkanes in the presence of transition metal catalysts such as Pt, Pd, or Ni. The reaction involves two sequential syn additions of hydrogen via a cis-alkene intermediate.
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Reduction of Alkenes: Catalytic Hydrogenation
Metals like palladium, platinum, and nickel are commonly used in their solid forms — fine powder on an inert surface. As these catalysts remain insoluble in the reaction mixture, they are referred to as heterogeneous catalysts.
The hydrogenation process takes place on the...
Preparation of Amines: Reduction of Amides and Nitriles
Amides can be reduced to primary, secondary, and tertiary amines using catalytic hydrogenation, active metals like Fe,...